首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis of novel quinoline based 4,5 dihydro-1H pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents
【24h】

Synthesis of novel quinoline based 4,5 dihydro-1H pyrazoles as potential anticancer, antifungal, antibacterial and antiprotozoal agents

机译:基于新型喹啉的4,5二氢-1H吡嗪作为潜在抗癌,抗真菌,抗菌和抗丙二醇剂的合成

获取原文
获取原文并翻译 | 示例
           

摘要

A new series of N-substituted 2-pyrazolines 9a-f, 10a-f, 11a-f, 12a-f and 13a-f were obtained from the cyclocondensation reaction of [(7-chloroquinolin-4-yl)amino]chalcones 8a-f with hydrazine hydrate and its derivatives. Fourteen of the synthesized compounds including the starting chalcones were selected by US National Cancer Institute (NCI) for testing their anticancer activity against 60 different human cancer cell lines, with the most important GI(50) values ranging from 0.28 to 11.7 mu M (0.13-6.05 mu g/mL) and LC50 values ranging from 2.6 to > 100 mu M (1.2 to > 51.7 mu g/mL), for chalcones 8a,d and pyrazolines 10c,d. All compounds were assessed for antibacterial activity against wild type and multidrug resistant gram negative and gram positive bacteria, with MIC values ranging from 31.25 to 500 mu g/mL. Additionally, the novel compounds were tested for antifungal and antiparasitic properties. Although these compounds showed mild activity against Candida albicans, chalcones 8a and 8e showed high activity against Cryptococcus neoformans with MIC50 = 7.8 mu g/mL. For anti-Plasmodium falciparum activity the 2-pyrazoline 11b was the most active with EC50 = 5.54 mu g/mL. Regarding the activity against Trypanosoma cruzi, compound 10a was highly active with EC50 = 0.70 mu g/mL. Chalcone 8a had good activity against Leishmania panamensis amastigotes with EC50 = 0.79 mu g/mL. (C) 2017 Elsevier Masson SAS. All rights reserved.
机译:从[(7-氯喹啉-4-基)氨基] Chalcones 8a的环酮反应得到新的N-取代的2-吡唑啉9a-F,10A-F,11a-F,12a-F和13a-F. -F与肼水合物及其衍生物。由美国国家癌症研究所(NCI)选择包括起始硫氨酸的合成化合物,用于针对60种不同的人类癌细胞系测试它们的抗癌活动,最重要的GI(50)值范围为0.28至11.7 mu m(0.13 -6.05μg/ ml)和LC50值范围为2.6->100μm(1.2至>51.7μg/ ml),用于Chalcones 8a,d和吡唑啉10c,d。评估所有化合物对野生型和多药抗革兰根阴性和革兰氏阳性细菌的抗菌活性,MIC值范围为31.25至500μg/ ml。另外,测试新化合物以进行抗真菌和抗抗原性能。虽然这些化合物对念珠菌蛋白糖醛糖醛糖尿病患者显示出轻度活动,但Chalcones 8a和8e对Crypocccus Neoformans的高活性显示为MIC50 =7.8μg/ ml。对于恶性疟原虫活性,2-吡唑啉11b是最活性的EC50 =5.54μg/ ml。关于针对锥虫瘤瘤的活性,化合物10a与EC50 =0.70μg/ ml高活性。 Chalcone 8A对EC50 =0.79μg/ ml的Leishmania Panmastigotes有良好的活动。 (c)2017年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号